Global Molecular Infectious Disease Testing Market Research Report 2026(Status and Outlook)

March 2026 | 181 pages | ID: GC9F9A1AC409EN
Bosson Research

Abstracts

Molecular Infectious Disease Testing refers to diagnostic tests that detect the genetic material (DNA or RNA) of infectious agents, such as bacteria, viruses, fungi, or parasites, to diagnose an infection. These tests are highly sensitive and can identify pathogens even when they are present in very low quantities, making them crucial for early detection and accurate diagnosis.

The global Molecular Infectious Disease Testing market size was estimated at USD 441.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.20% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Molecular Infectious Disease Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Molecular Infectious Disease Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Molecular Infectious Disease Testing market.

Global Molecular Infectious Disease Testing Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Danaher
Roche
bioM?rieux
Hologic
Abbott
Thermo Fisher Scientific
QIAGEN
Revvity
Grifols
Seegene
DiaSorin
Siemens Healthineers
BD
QuidelOrtho
Bruker
Genetic Signatures
Co-Diagnostics
Vela Diagnostics
Molbio Diagnostics
Savyon Diagnostics
Uniogen Oy
geneOmbio Technologies
Advanced Molecular Diagnostics
altona Diagnostics
GeneFirst

Market Segmentation (by Type)

Multiplex Testing
Singleplex Testing

Market Segmentation (by Application)

Diagnostic Laboratories
Hospitals and Clinics
Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Molecular Infectious Disease Testing Market
Overview of the regional outlook of the Molecular Infectious Disease Testing Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Infectious Disease Testing Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Molecular Infectious Disease Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Molecular Infectious Disease Testing
1.2 Key Market Segments
  1.2.1 Molecular Infectious Disease Testing Segment by Type
  1.2.2 Molecular Infectious Disease Testing Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 MOLECULAR INFECTIOUS DISEASE TESTING MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Molecular Infectious Disease Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Molecular Infectious Disease Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 MOLECULAR INFECTIOUS DISEASE TESTING MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Molecular Infectious Disease Testing Product Life Cycle
3.3 Global Molecular Infectious Disease Testing Sales by Manufacturers (2020-2025)
3.4 Global Molecular Infectious Disease Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Molecular Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Molecular Infectious Disease Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Molecular Infectious Disease Testing Market Competitive Situation and Trends
  3.8.1 Molecular Infectious Disease Testing Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Molecular Infectious Disease Testing Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 MOLECULAR INFECTIOUS DISEASE TESTING INDUSTRY CHAIN ANALYSIS

4.1 Molecular Infectious Disease Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF MOLECULAR INFECTIOUS DISEASE TESTING MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Molecular Infectious Disease Testing Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Molecular Infectious Disease Testing Market
5.7 ESG Ratings of Leading Companies

6 MOLECULAR INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Molecular Infectious Disease Testing Sales Market Share by Type (2020-2025)
6.3 Global Molecular Infectious Disease Testing Market Size by Type (2020-2025)
6.4 Global Molecular Infectious Disease Testing Price by Type (2020-2025)

7 MOLECULAR INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Molecular Infectious Disease Testing Market Sales by Application (2020-2025)
7.3 Global Molecular Infectious Disease Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Molecular Infectious Disease Testing Sales Growth Rate by Application (2020-2025)

8 MOLECULAR INFECTIOUS DISEASE TESTING MARKET SALES BY REGION

8.1 Global Molecular Infectious Disease Testing Sales by Region
  8.1.1 Global Molecular Infectious Disease Testing Sales by Region
  8.1.2 Global Molecular Infectious Disease Testing Sales Market Share by Region
8.2 Global Molecular Infectious Disease Testing Market Size by Region
  8.2.1 Global Molecular Infectious Disease Testing Market Size by Region
  8.2.2 Global Molecular Infectious Disease Testing Market Size by Region
8.3 North America
  8.3.1 North America Molecular Infectious Disease Testing Sales by Country
  8.3.2 North America Molecular Infectious Disease Testing Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Molecular Infectious Disease Testing Sales by Country
  8.4.2 Europe Molecular Infectious Disease Testing Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Molecular Infectious Disease Testing Sales by Region
  8.5.2 Asia Pacific Molecular Infectious Disease Testing Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Molecular Infectious Disease Testing Sales by Country
  8.6.2 South America Molecular Infectious Disease Testing Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Molecular Infectious Disease Testing Sales by Region
  8.7.2 Middle East and Africa Molecular Infectious Disease Testing Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 MOLECULAR INFECTIOUS DISEASE TESTING MARKET PRODUCTION BY REGION

9.1 Global Production of Molecular Infectious Disease Testing by Region(2020-2025)
9.2 Global Molecular Infectious Disease Testing Revenue Market Share by Region (2020-2025)
9.3 Global Molecular Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Molecular Infectious Disease Testing Production
  9.4.1 North America Molecular Infectious Disease Testing Production Growth Rate (2020-2025)
  9.4.2 North America Molecular Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Molecular Infectious Disease Testing Production
  9.5.1 Europe Molecular Infectious Disease Testing Production Growth Rate (2020-2025)
  9.5.2 Europe Molecular Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Molecular Infectious Disease Testing Production (2020-2025)
  9.6.1 Japan Molecular Infectious Disease Testing Production Growth Rate (2020-2025)
  9.6.2 Japan Molecular Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Molecular Infectious Disease Testing Production (2020-2025)
  9.7.1 China Molecular Infectious Disease Testing Production Growth Rate (2020-2025)
  9.7.2 China Molecular Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Danaher
  10.1.1 Danaher Basic Information
  10.1.2 Danaher Molecular Infectious Disease Testing Product Overview
  10.1.3 Danaher Molecular Infectious Disease Testing Product Market Performance
  10.1.4 Danaher Business Overview
  10.1.5 Danaher SWOT Analysis
  10.1.6 Danaher Recent Developments
10.2 Roche
  10.2.1 Roche Basic Information
  10.2.2 Roche Molecular Infectious Disease Testing Product Overview
  10.2.3 Roche Molecular Infectious Disease Testing Product Market Performance
  10.2.4 Roche Business Overview
  10.2.5 Roche SWOT Analysis
  10.2.6 Roche Recent Developments
10.3 bioM?rieux
  10.3.1 bioM?rieux Basic Information
  10.3.2 bioM?rieux Molecular Infectious Disease Testing Product Overview
  10.3.3 bioM?rieux Molecular Infectious Disease Testing Product Market Performance
  10.3.4 bioM?rieux Business Overview
  10.3.5 bioM?rieux SWOT Analysis
  10.3.6 bioM?rieux Recent Developments
10.4 Hologic
  10.4.1 Hologic Basic Information
  10.4.2 Hologic Molecular Infectious Disease Testing Product Overview
  10.4.3 Hologic Molecular Infectious Disease Testing Product Market Performance
  10.4.4 Hologic Business Overview
  10.4.5 Hologic Recent Developments
10.5 Abbott
  10.5.1 Abbott Basic Information
  10.5.2 Abbott Molecular Infectious Disease Testing Product Overview
  10.5.3 Abbott Molecular Infectious Disease Testing Product Market Performance
  10.5.4 Abbott Business Overview
  10.5.5 Abbott Recent Developments
10.6 Thermo Fisher Scientific
  10.6.1 Thermo Fisher Scientific Basic Information
  10.6.2 Thermo Fisher Scientific Molecular Infectious Disease Testing Product Overview
  10.6.3 Thermo Fisher Scientific Molecular Infectious Disease Testing Product Market Performance
  10.6.4 Thermo Fisher Scientific Business Overview
  10.6.5 Thermo Fisher Scientific Recent Developments
10.7 QIAGEN
  10.7.1 QIAGEN Basic Information
  10.7.2 QIAGEN Molecular Infectious Disease Testing Product Overview
  10.7.3 QIAGEN Molecular Infectious Disease Testing Product Market Performance
  10.7.4 QIAGEN Business Overview
  10.7.5 QIAGEN Recent Developments
10.8 Revvity
  10.8.1 Revvity Basic Information
  10.8.2 Revvity Molecular Infectious Disease Testing Product Overview
  10.8.3 Revvity Molecular Infectious Disease Testing Product Market Performance
  10.8.4 Revvity Business Overview
  10.8.5 Revvity Recent Developments
10.9 Grifols
  10.9.1 Grifols Basic Information
  10.9.2 Grifols Molecular Infectious Disease Testing Product Overview
  10.9.3 Grifols Molecular Infectious Disease Testing Product Market Performance
  10.9.4 Grifols Business Overview
  10.9.5 Grifols Recent Developments
10.10 Seegene
  10.10.1 Seegene Basic Information
  10.10.2 Seegene Molecular Infectious Disease Testing Product Overview
  10.10.3 Seegene Molecular Infectious Disease Testing Product Market Performance
  10.10.4 Seegene Business Overview
  10.10.5 Seegene Recent Developments
10.11 DiaSorin
  10.11.1 DiaSorin Basic Information
  10.11.2 DiaSorin Molecular Infectious Disease Testing Product Overview
  10.11.3 DiaSorin Molecular Infectious Disease Testing Product Market Performance
  10.11.4 DiaSorin Business Overview
  10.11.5 DiaSorin Recent Developments
10.12 Siemens Healthineers
  10.12.1 Siemens Healthineers Basic Information
  10.12.2 Siemens Healthineers Molecular Infectious Disease Testing Product Overview
  10.12.3 Siemens Healthineers Molecular Infectious Disease Testing Product Market Performance
  10.12.4 Siemens Healthineers Business Overview
  10.12.5 Siemens Healthineers Recent Developments
10.13 BD
  10.13.1 BD Basic Information
  10.13.2 BD Molecular Infectious Disease Testing Product Overview
  10.13.3 BD Molecular Infectious Disease Testing Product Market Performance
  10.13.4 BD Business Overview
  10.13.5 BD Recent Developments
10.14 QuidelOrtho
  10.14.1 QuidelOrtho Basic Information
  10.14.2 QuidelOrtho Molecular Infectious Disease Testing Product Overview
  10.14.3 QuidelOrtho Molecular Infectious Disease Testing Product Market Performance
  10.14.4 QuidelOrtho Business Overview
  10.14.5 QuidelOrtho Recent Developments
10.15 Bruker
  10.15.1 Bruker Basic Information
  10.15.2 Bruker Molecular Infectious Disease Testing Product Overview
  10.15.3 Bruker Molecular Infectious Disease Testing Product Market Performance
  10.15.4 Bruker Business Overview
  10.15.5 Bruker Recent Developments
10.16 Genetic Signatures
  10.16.1 Genetic Signatures Basic Information
  10.16.2 Genetic Signatures Molecular Infectious Disease Testing Product Overview
  10.16.3 Genetic Signatures Molecular Infectious Disease Testing Product Market Performance
  10.16.4 Genetic Signatures Business Overview
  10.16.5 Genetic Signatures Recent Developments
10.17 Co-Diagnostics
  10.17.1 Co-Diagnostics Basic Information
  10.17.2 Co-Diagnostics Molecular Infectious Disease Testing Product Overview
  10.17.3 Co-Diagnostics Molecular Infectious Disease Testing Product Market Performance
  10.17.4 Co-Diagnostics Business Overview
  10.17.5 Co-Diagnostics Recent Developments
10.18 Vela Diagnostics
  10.18.1 Vela Diagnostics Basic Information
  10.18.2 Vela Diagnostics Molecular Infectious Disease Testing Product Overview
  10.18.3 Vela Diagnostics Molecular Infectious Disease Testing Product Market Performance
  10.18.4 Vela Diagnostics Business Overview
  10.18.5 Vela Diagnostics Recent Developments
10.19 Molbio Diagnostics
  10.19.1 Molbio Diagnostics Basic Information
  10.19.2 Molbio Diagnostics Molecular Infectious Disease Testing Product Overview
  10.19.3 Molbio Diagnostics Molecular Infectious Disease Testing Product Market Performance
  10.19.4 Molbio Diagnostics Business Overview
  10.19.5 Molbio Diagnostics Recent Developments
10.20 Savyon Diagnostics
  10.20.1 Savyon Diagnostics Basic Information
  10.20.2 Savyon Diagnostics Molecular Infectious Disease Testing Product Overview
  10.20.3 Savyon Diagnostics Molecular Infectious Disease Testing Product Market Performance
  10.20.4 Savyon Diagnostics Business Overview
  10.20.5 Savyon Diagnostics Recent Developments
10.21 Uniogen Oy
  10.21.1 Uniogen Oy Basic Information
  10.21.2 Uniogen Oy Molecular Infectious Disease Testing Product Overview
  10.21.3 Uniogen Oy Molecular Infectious Disease Testing Product Market Performance
  10.21.4 Uniogen Oy Business Overview
  10.21.5 Uniogen Oy Recent Developments
10.22 geneOmbio Technologies
  10.22.1 geneOmbio Technologies Basic Information
  10.22.2 geneOmbio Technologies Molecular Infectious Disease Testing Product Overview
  10.22.3 geneOmbio Technologies Molecular Infectious Disease Testing Product Market Performance
  10.22.4 geneOmbio Technologies Business Overview
  10.22.5 geneOmbio Technologies Recent Developments
10.23 Advanced Molecular Diagnostics
  10.23.1 Advanced Molecular Diagnostics Basic Information
  10.23.2 Advanced Molecular Diagnostics Molecular Infectious Disease Testing Product Overview
  10.23.3 Advanced Molecular Diagnostics Molecular Infectious Disease Testing Product Market Performance
  10.23.4 Advanced Molecular Diagnostics Business Overview
  10.23.5 Advanced Molecular Diagnostics Recent Developments
10.24 altona Diagnostics
  10.24.1 altona Diagnostics Basic Information
  10.24.2 altona Diagnostics Molecular Infectious Disease Testing Product Overview
  10.24.3 altona Diagnostics Molecular Infectious Disease Testing Product Market Performance
  10.24.4 altona Diagnostics Business Overview
  10.24.5 altona Diagnostics Recent Developments
10.25 GeneFirst
  10.25.1 GeneFirst Basic Information
  10.25.2 GeneFirst Molecular Infectious Disease Testing Product Overview
  10.25.3 GeneFirst Molecular Infectious Disease Testing Product Market Performance
  10.25.4 GeneFirst Business Overview
  10.25.5 GeneFirst Recent Developments

11 MOLECULAR INFECTIOUS DISEASE TESTING MARKET FORECAST BY REGION

11.1 Global Molecular Infectious Disease Testing Market Size Forecast
11.2 Global Molecular Infectious Disease Testing Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Molecular Infectious Disease Testing Market Size Forecast by Country
  11.2.3 Asia Pacific Molecular Infectious Disease Testing Market Size Forecast by Region
  11.2.4 South America Molecular Infectious Disease Testing Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Molecular Infectious Disease Testing by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Molecular Infectious Disease Testing Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Molecular Infectious Disease Testing by Type (2026-2035)
  12.1.2 Global Molecular Infectious Disease Testing Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Molecular Infectious Disease Testing by Type (2026-2035)
12.2 Global Molecular Infectious Disease Testing Market Forecast by Application (2026-2035)
  12.2.1 Global Molecular Infectious Disease Testing Sales (K Units) Forecast by Application
  12.2.2 Global Molecular Infectious Disease Testing Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Molecular Infectious Disease Testing Market Size by Type (M USD)
Table 4. Global Molecular Infectious Disease Testing Market Size by Application
Table 5. Molecular Infectious Disease Testing Market Size Comparison by Region (M USD)
Table 6. Global Molecular Infectious Disease Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Molecular Infectious Disease Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Molecular Infectious Disease Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Molecular Infectious Disease Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Infectious Disease Testing as of 2025)
Table 11. Global Market Molecular Infectious Disease Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Molecular Infectious Disease Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Molecular Infectious Disease Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Molecular Infectious Disease Testing Sales by Type (K Units)
Table 27. Global Molecular Infectious Disease Testing Market Size by Type (M USD)
Table 28. Global Molecular Infectious Disease Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Molecular Infectious Disease Testing Sales Market Share by Type (2020-2025)
Table 30. Global Molecular Infectious Disease Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Molecular Infectious Disease Testing Market Share by Type (2020-2025)
Table 32. Global Molecular Infectious Disease Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Molecular Infectious Disease Testing Sales (K Units) by Application
Table 34. Global Molecular Infectious Disease Testing Market Size by Application
Table 35. Global Molecular Infectious Disease Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Molecular Infectious Disease Testing Sales Market Share by Application (2020-2025)
Table 37. Global Molecular Infectious Disease Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Molecular Infectious Disease Testing Market Share by Application (2020-2025)
Table 39. Global Molecular Infectious Disease Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Molecular Infectious Disease Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Molecular Infectious Disease Testing Sales Market Share by Region (2020-2025)
Table 42. Global Molecular Infectious Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Molecular Infectious Disease Testing Market Size by Region (2020-2025)
Table 44. North America Molecular Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Molecular Infectious Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Molecular Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Molecular Infectious Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Molecular Infectious Disease Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Molecular Infectious Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Molecular Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Molecular Infectious Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Molecular Infectious Disease Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Molecular Infectious Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Molecular Infectious Disease Testing Production (K Units) by Region(2020-2025)
Table 55. Global Molecular Infectious Disease Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Molecular Infectious Disease Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Molecular Infectious Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Molecular Infectious Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Molecular Infectious Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Molecular Infectious Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Molecular Infectious Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Danaher Basic Information
Table 63. Danaher Molecular Infectious Disease Testing Product Overview
Table 64. Danaher Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Danaher Business Overview
Table 66. Danaher SWOT Analysis
Table 67. Danaher Recent Developments
Table 68. Roche Basic Information
Table 69. Roche Molecular Infectious Disease Testing Product Overview
Table 70. Roche Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Roche Business Overview
Table 72. Roche SWOT Analysis
Table 73. Roche Recent Developments
Table 74. bioM?rieux Basic Information
Table 75. bioM?rieux Molecular Infectious Disease Testing Product Overview
Table 76. bioM?rieux Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. bioM?rieux Business Overview
Table 78. bioM?rieux SWOT Analysis
Table 79. bioM?rieux Recent Developments
Table 80. Hologic Basic Information
Table 81. Hologic Molecular Infectious Disease Testing Product Overview
Table 82. Hologic Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Hologic Business Overview
Table 84. Hologic Recent Developments
Table 85. Abbott Basic Information
Table 86. Abbott Molecular Infectious Disease Testing Product Overview
Table 87. Abbott Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Abbott Business Overview
Table 89. Abbott Recent Developments
Table 90. Thermo Fisher Scientific Basic Information
Table 91. Thermo Fisher Scientific Molecular Infectious Disease Testing Product Overview
Table 92. Thermo Fisher Scientific Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Thermo Fisher Scientific Business Overview
Table 94. Thermo Fisher Scientific Recent Developments
Table 95. QIAGEN Basic Information
Table 96. QIAGEN Molecular Infectious Disease Testing Product Overview
Table 97. QIAGEN Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. QIAGEN Business Overview
Table 99. QIAGEN Recent Developments
Table 100. Revvity Basic Information
Table 101. Revvity Molecular Infectious Disease Testing Product Overview
Table 102. Revvity Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Revvity Business Overview
Table 104. Revvity Recent Developments
Table 105. Grifols Basic Information
Table 106. Grifols Molecular Infectious Disease Testing Product Overview
Table 107. Grifols Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Grifols Business Overview
Table 109. Grifols Recent Developments
Table 110. Seegene Basic Information
Table 111. Seegene Molecular Infectious Disease Testing Product Overview
Table 112. Seegene Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Seegene Business Overview
Table 114. Seegene Recent Developments
Table 115. DiaSorin Basic Information
Table 116. DiaSorin Molecular Infectious Disease Testing Product Overview
Table 117. DiaSorin Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. DiaSorin Business Overview
Table 119. DiaSorin Recent Developments
Table 120. Siemens Healthineers Basic Information
Table 121. Siemens Healthineers Molecular Infectious Disease Testing Product Overview
Table 122. Siemens Healthineers Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Siemens Healthineers Business Overview
Table 124. Siemens Healthineers Recent Developments
Table 125. BD Basic Information
Table 126. BD Molecular Infectious Disease Testing Product Overview
Table 127. BD Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. BD Business Overview
Table 129. BD Recent Developments
Table 130. QuidelOrtho Basic Information
Table 131. QuidelOrtho Molecular Infectious Disease Testing Product Overview
Table 132. QuidelOrtho Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. QuidelOrtho Business Overview
Table 134. QuidelOrtho Recent Developments
Table 135. Bruker Basic Information
Table 136. Bruker Molecular Infectious Disease Testing Product Overview
Table 137. Bruker Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Bruker Business Overview
Table 139. Bruker Recent Developments
Table 140. Genetic Signatures Basic Information
Table 141. Genetic Signatures Molecular Infectious Disease Testing Product Overview
Table 142. Genetic Signatures Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Genetic Signatures Business Overview
Table 144. Genetic Signatures Recent Developments
Table 145. Co-Diagnostics Basic Information
Table 146. Co-Diagnostics Molecular Infectious Disease Testing Product Overview
Table 147. Co-Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Co-Diagnostics Business Overview
Table 149. Co-Diagnostics Recent Developments
Table 150. Vela Diagnostics Basic Information
Table 151. Vela Diagnostics Molecular Infectious Disease Testing Product Overview
Table 152. Vela Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Vela Diagnostics Business Overview
Table 154. Vela Diagnostics Recent Developments
Table 155. Molbio Diagnostics Basic Information
Table 156. Molbio Diagnostics Molecular Infectious Disease Testing Product Overview
Table 157. Molbio Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Molbio Diagnostics Business Overview
Table 159. Molbio Diagnostics Recent Developments
Table 160. Savyon Diagnostics Basic Information
Table 161. Savyon Diagnostics Molecular Infectious Disease Testing Product Overview
Table 162. Savyon Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Savyon Diagnostics Business Overview
Table 164. Savyon Diagnostics Recent Developments
Table 165. Uniogen Oy Basic Information
Table 166. Uniogen Oy Molecular Infectious Disease Testing Product Overview
Table 167. Uniogen Oy Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Uniogen Oy Business Overview
Table 169. Uniogen Oy Recent Developments
Table 170. geneOmbio Technologies Basic Information
Table 171. geneOmbio Technologies Molecular Infectious Disease Testing Product Overview
Table 172. geneOmbio Technologies Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. geneOmbio Technologies Business Overview
Table 174. geneOmbio Technologies Recent Developments
Table 175. Advanced Molecular Diagnostics Basic Information
Table 176. Advanced Molecular Diagnostics Molecular Infectious Disease Testing Product Overview
Table 177. Advanced Molecular Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Advanced Molecular Diagnostics Business Overview
Table 179. Advanced Molecular Diagnostics Recent Developments
Table 180. altona Diagnostics Basic Information
Table 181. altona Diagnostics Molecular Infectious Disease Testing Product Overview
Table 182. altona Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. altona Diagnostics Business Overview
Table 184. altona Diagnostics Recent Developments
Table 185. GeneFirst Basic Information
Table 186. GeneFirst Molecular Infectious Disease Testing Product Overview
Table 187. GeneFirst Molecular Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 188. GeneFirst Business Overview
Table 189. GeneFirst Recent Developments
Table 190. Global Molecular Infectious Disease Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 191. Global Molecular Infectious Disease Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 192. North America Molecular Infectious Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 193. North America Molecular Infectious Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 194. Europe Molecular Infectious Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 195. Europe Molecular Infectious Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 196. Asia Pacific Molecular Infectious Disease Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 197. Asia Pacific Molecular Infectious Disease Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 198. South America Molecular Infectious Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 199. South America Molecular Infectious Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 200. Middle East and Africa Molecular Infectious Disease Testing Sales Forecast by Country (2026-2035) & (Units)
Table 201. Middle East and Africa Molecular Infectious Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 202. Global Molecular Infectious Disease Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 203. Global Molecular Infectious Disease Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 204. Global Molecular Infectious Disease Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 205. Global Molecular Infectious Disease Testing Sales (K Units) Forecast by Application (2026-2035)
Table 206. Global Molecular Infectious Disease Testing Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Molecular Infectious Disease Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Molecular Infectious Disease Testing Market Size (M USD), 2025-2035
Figure 5. Global Molecular Infectious Disease Testing Market Size (M USD) (2020-2035)
Figure 6. Global Molecular Infectious Disease Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Molecular Infectious Disease Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Molecular Infectious Disease Testing Product Life Cycle
Figure 13. Molecular Infectious Disease Testing Sales Share by Manufacturers in 2025
Figure 14. Global Molecular Infectious Disease Testing Revenue Share by Manufacturers in 2025
Figure 15. Molecular Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Molecular Infectious Disease Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Molecular Infectious Disease Testing Revenue in 2025
Figure 18. Industry Chain Map of Molecular Infectious Disease Testing
Figure 19. Global Molecular Infectious Disease Testing Market PEST Analysis
Figure 20. Global Molecular Infectious Disease Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Molecular Infectious Disease Testing Market Share by Type
Figure 27. Sales Market Share of Molecular Infectious Disease Testing by Type (2020-2025)
Figure 28. Sales Market Share of Molecular Infectious Disease Testing by Type in 2025
Figure 29. Market Share of Molecular Infectious Disease Testing by Type (2020-2025)
Figure 30. Market Share of Molecular Infectious Disease Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Molecular Infectious Disease Testing Market Share by Application
Figure 33. Global Molecular Infectious Disease Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Molecular Infectious Disease Testing Sales Market Share by Application in 2025
Figure 35. Global Molecular Infectious Disease Testing Market Share by Application (2020-2025)
Figure 36. Global Molecular Infectious Disease Testing Market Share by Application in 2025
Figure 37. Global Molecular Infectious Disease Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Molecular Infectious Disease Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Molecular Infectious Disease Testing Market Size by Region (2020-2025)
Figure 40. North America Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Molecular Infectious Disease Testing Sales Market Share by Country in 2024
Figure 43. North America Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Molecular Infectious Disease Testing Market Size by Country in 2024
Figure 45. U.S. Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Molecular Infectious Disease Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Molecular Infectious Disease Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Molecular Infectious Disease Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Molecular Infectious Disease Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Molecular Infectious Disease Testing Sales Market Share by Country in 2024
Figure 53. Europe Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Molecular Infectious Disease Testing Market Size by Country in 2024
Figure 55. Germany Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Molecular Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Molecular Infectious Disease Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Molecular Infectious Disease Testing Market Size by Region in 2024
Figure 68. China Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Molecular Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 79. South America Molecular Infectious Disease Testing Sales Market Share by Country in 2024
Figure 80. South America Molecular Infectious Disease Testing Market Size and Growth Rate (M USD)
Figure 81. South America Molecular Infectious Disease Testing Market Size by Country in 2024
Figure 82. Brazil Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Molecular Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Molecular Infectious Disease Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Molecular Infectious Disease Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Molecular Infectious Disease Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Molecular Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Molecular Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Molecular Infectious Disease Testing Production Market Share by Region (2020-2025)
Figure 103. North America Molecular Infectious Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Molecular Infectious Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Molecular Infectious Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Molecular Infectious Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Molecular Infectious Disease Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Molecular Infectious Disease Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Molecular Infectious Disease Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Molecular Infectious Disease Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Molecular Infectious Disease Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Molecular Infectious Disease Testing Market Share Forecast by Application (2026-2035)